Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Classic Kaposi sarcoma: Epidemiology and risk factors
Jose Iscovich
*
, Paolo Boffetta
, Silvia Franceschi
,
Esther Azizi
, Ronit Sarid
*
Corresponding author for this work
Clinical Departments
Selikoff Ctr. Environ. Hlth. Hum. D.
International Fertility Institute
International Agency for Research on Cancer
IRCCS Centro di Riferimento Oncologico - Aviano PN
Bar-Ilan University
Research output
:
Contribution to journal
›
Review article
›
peer-review
247
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Classic Kaposi sarcoma: Epidemiology and risk factors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Risk Factors
100%
Epidemiology
100%
Kaposi Sarcoma
100%
HHV-8
41%
Herpesvirus
33%
Virus
16%
Europe
16%
AIDS/HIV
16%
Etiology
8%
Africa
8%
Incidence Rate
8%
Immunodeficiency Diseases
8%
Host Immune Response
8%
Older Men
8%
All Languages
8%
Human DNA
8%
Bioelectronic Medicine
8%
Mediterranean Countries
8%
Seroprevalence
8%
Contributory Factors
8%
Kaposi's Sarcoma-associated Herpesvirus
8%
Eastern European
8%
Iatrogenic Immunosuppression
8%
Multiple Information Sources
8%
Universal Detection
8%
DNA Virus Infection
8%
Agricultural and Biological Sciences
Risk Factor
100%
Human Herpesvirus 8
100%
Herpesviridae
66%
Biological Sciences
33%
Human Immunodeficiency Virus
33%
Immune Response
16%
Seroprevalence
16%
Information Source
16%
DNA Virus
16%
Medicine and Dentistry
Cohort Effect
100%
Kaposi Sarcoma
100%
Human Herpesvirus 8
50%
Herpesviridae
33%
Human Immunodeficiency Virus
16%
Virus
16%
Prevalence
8%
Morphology
8%
Immune Deficiency
8%
Immune Response
8%
Pathogen
8%
Seroprevalence
8%
DNA Virus Infection
8%
Diseases
8%
Immunology and Microbiology
Human Herpesvirus 8
100%
Herpesviridae
66%
Human Immunodeficiency Virus
33%
Virus
33%
Infectious Agent
16%
Prevalence
16%
Morphology
16%
Immunodeficiency
16%
Viral Disease
16%
Seroprevalence
16%
Host Immune Response
16%
DNA Virus
16%
Biochemistry, Genetics and Molecular Biology
Human Herpesvirus 8
100%
Herpesviridae
66%
Human Immunodeficiency Virus
33%
Prevalence
16%
Infectious Agent
16%
Morphology
16%
Immune Response
16%
Seroprevalence
16%
DNA Virus
16%
Veterinary Science and Veterinary Medicine
Kaposi Sarcoma
100%
Herpesviridae
76%
Prevalence
7%
Virus Infection
7%
Seroprevalence
7%